PMDA adds June 2026 information on suspected adverse drug reaction case reports
「副作用が疑われる症例報告に関する情報」に2026年6月分の情報を追加しました
Published: 2026-10-16 · Source: Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Medium · First detected by this dashboard: 2026-10-16
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
The Pharmaceuticals and Medical Devices Agency (PMDA) announced on 2026-10-16 that June 2026 information had been added to its suspected adverse drug reaction case reports page. This is a safety-information update; the title does not identify particular drugs or reported reactions.
Business Impact
Pharmaceutical companies may find the added case-report information relevant to drug-safety monitoring, but the title does not establish any product-specific implications.
Recommended Action
Reviewing the official PMDA page could clarify which drugs and suspected reactions are covered by the June 2026 information.